Justin J. MahramasAssociateSheppard, Mullin, Richter & Hampton LLPWebsitewww.sheppardmullin.comOrganization ProfileFull ProfileConnectEmail1.213.617.4101 Professional Biography Justin Mahramas is an associate in the Real Estate Land Use and Environmental Practice Group in the firm's Los Angeles office. More Legal and Business Bylines From Justin J. Mahramas A New Hope for the Future of Mitigated Negative Declarations: The Logistics of Warehouse Storage Greenhouse Gas Analysis - (Posted On Thursday, October 17, 2024) Westside Mobility Plan Clears the Road of CEQA Challenges - (Posted On Wednesday, October 09, 2024) CEQA 2023 Legislative Update - (Posted On Tuesday, January 09, 2024) Los Angeles Mayor Signs New Legislation Exempting Affordable Housing Projects from Site Plan Review - (Posted On Tuesday, July 18, 2023) Measure ULA May Not Measure Up - (Posted On Tuesday, June 13, 2023) Significant Changes to State CEQA Filing and Noticing Requirements and Procedures - (Posted On Thursday, November 12, 2020) Sustainable Communities Environmental Assessment Upheld Under CEQA - (Posted On Monday, August 05, 2019) Current Legal Analysis FDA Approves Three New Natural Food Colors by: Food and Drug Law at Keller and Heckman Coalition of States Dispute Trump Administration’s “National Energy Emergency” Claim by: Peter R. Knight FDA and HHS Announce Next Steps in “Operation Stork Speed” by: Food and Drug Law at Keller and Heckman Hatch-Waxman or Not, Clinical Trials Aren’t Subject to Injunction by: Christopher M. Bruno District Court Holds Pension Fund Misapplied Prior Partial Withdrawal Liability Credit by: Neil V. Shah , Sydney L. Juliano FDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities by: Food and Drug Law at Keller and Heckman No Protectable Code: No Literal or Nonliteral Copying by: Keval Amin FDA and NIH Launch Joint Nutrition Regulatory Science Program by: Food and Drug Law at Keller and Heckman Up in Smoke: Statutory Trademark Damages Can Exceed Actual Damages by: Taylor MacDonald FDA Extends Comment Period for Front-of-Package Nutrition Labeling Rule by: Food and Drug Law at Keller and Heckman U.S. State PFAS Initiatives — A Conversation with Richard E. Engler, Ph.D. and Carla N. Hutton [Podcast] by: Lynn L. Bergeson FDA Releases 2023 CORE Annual Report by: Food and Drug Law at Keller and Heckman Complaint Need Not Allege Fraud, Misrepresentation, Or Deceit To Be "Based Upon" A Corporation’s “Fraud, Misrepresentation or Deceit" by: Keith Paul Bishop FDA to Rehire Some Staff by: Food and Drug Law at Keller and Heckman BIS Issues Four Key Updates on Advanced Computing and AI Export Controls by: Anthony Rapa , Alan Kashdan Upcoming Events May 22 2025 Kidd Aitken & Chambers USA Q&A May 15 2025 L&E Global Immigration Webinar Series | Strategic Expansion of U.S. Companies in Portugal and Spain: Setting Up Branches and Immigration Pathway May 15 2025 Using Extrinsic Evidence to Determine the Duty to Defend: Eight Corners, Four Corners, or No Corners? May 15 2025 Discovering Weaknesses; Protecting Work Product; Coordinating With Expert Discovery Print
